Association between matrix metalloproteinase-2 gene variants and pathogenesis of breast cancer in sera of Iraqi women

被引:1
|
作者
Abbas, Yammamah Jawad [1 ]
Al-Tu'ma, Fadhil Jawad [1 ]
Al-Hemerri, Alaa Fraq [2 ]
机构
[1] Univ Kerbala, Coll Med, Dept Chem & Biochem, Kerbala, Iraq
[2] Univ Kerbala, Coll Sci, Dept Chem, Kerbala, Iraq
来源
关键词
MMP-2; breast cancer; allele; polymerase chain reaction; genotype; SNP; POLYMORPHISMS; RISK; MATRIX-METALLOPROTEINASE-2; PROGRESSION; PROMOTERS;
D O I
10.22317/jcms.v6i6.887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The current study aims to investigate the role of matrix metalloproteinase-2 (MMP-2) in breast cancer pathogenesis in Iraqi women. Methods: Forty-one (41) women with breast cancer and 45 control women were included in this case-control study. Body mass index, age, smoking; married status, tumor size, degree, subtype, lymph node status, pre- and post-menopause were included the phenotypic results. The polymerase chain reaction (PCR)-allele specific restriction was used to observe the rs243865 polymorphism. Genomic DNA was extracted from whole blood and genotyping with specific prefixes for amplification of the MMP-2 gene was accomplished as enzyme-restricted PCR products were digested, followed by electrophoresis on 1.5% agarose gel. In order to interpret the researchers' results, numerous statistical analyses were applied. Results: The amplicon size of MMP-2 gene was 304 bp, and following its amplification reactions by allelic specific PCR. The amplification product for MMP-2 gene amplification SNP rs243865 gene polymorphism results exhibited one band of 304 bp, two bands of 304 bp, and one band 304 bp for individuals have genotype as wild type (CC), homozygous ( TT), and heterozygous (CT), respectively. Genotype frequencies of rs243865 polymorphism were found to be consistent with Hardy-Weinberg equilibrium. Allele frequencies of C allele was 0.57, and the T allele was only 0.43 in cases of breast cancer women patient, while the frequencies of CC, CT, and TT genotypes of the rs243865 SNP were statistically significant as 31.7%, 51.2%, 17.1%, respectively. Allele frequencies of C and T were 0.78 and 0.22 for the control group, respectively, the heterozygous genotype (CT) was significantly increased the risk of breast cancer women (OR=0.3, 95% CI; 0.12-0.8, P=0.05) with respect to those of the CC wild type. The TT genotype significantly raised the risk of breast cancer women by (OR = 0.2, 95% CI; 0.04-0.9, P=0.05). Conclusion: In women with breast cancer, MMP-2 expression's high association were observed with positive lymph node, histological classification of breast cancer (ll) was higher than other classes and advanced clinical process (ll).
引用
收藏
页码:285 / 290
页数:6
相关论文
共 50 条
  • [21] An association between the matrix metalloproteinase 1 promoter gene polymorphism and lymphnode metastasis in breast cancer
    Przybylowska, K
    Zielinska, J
    Zadrozny, M
    Krawczyk, T
    Kulig, A
    Wozniak, P
    Rykala, J
    Kolacinska, A
    Morawiec, Z
    Drzewoski, J
    Blasiak, J
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (01) : 121 - 125
  • [22] Preoperative Serum Levels of Matrix Metalloproteinase-2 (MMP-2) and Survival of Breast Cancer among Korean Women
    Song, Nan
    Sung, Hyuna
    Choi, Ji-Yeob
    Han, Sohee
    Jeon, Sujee
    Song, Minkyo
    Lee, Yunhee
    Park, Chulbum
    Park, Sue K.
    Lee, Kyoung-Mu
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Sei-Hyun
    Lee, Sang-Ah
    Kang, Daehee
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (08) : 1371 - 1380
  • [23] Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women
    Song, Nan
    Sung, Hyuna
    Jeon, Sujee
    Lee, Yunhee
    Choi, Ji-Yeob
    Park, Sue K.
    Lee, Kyoung-Mu
    Yoo, Keun-Young
    Noh, Dong-Young
    Ahn, Se-Hyun
    Lee, Sang-Ah
    Kang, Daehee
    [J]. CANCER RESEARCH, 2012, 72
  • [24] Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Yvonne
    Vasku, Anna
    Stourac, Pavel
    Hladikova, Magdalena
    Beranek, Michal
    Kadanka, Zdenek
    Novotna, Hana
    Bednarik, Josef
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2008, 205 (1-2) : 105 - 109
  • [25] Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
    Kanayama, H
    Yokota, K
    Kurokawa, Y
    Murakami, Y
    Nishitani, M
    Kagawa, S
    [J]. CANCER, 1998, 82 (07) : 1359 - 1366
  • [26] Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Yvonne
    Vasku, Anna
    Stourac, Pavel
    Hladikova, Magdalena
    Beranek, Michal
    Kadanka, Zdenek
    Bednarik, Josef
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S59 - S59
  • [27] Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes
    Zhou, YF
    Yu, CY
    Miao, XP
    Tan, W
    Liang, G
    Xiong, P
    Sun, T
    Lin, DX
    [J]. CARCINOGENESIS, 2004, 25 (03) : 399 - 404
  • [28] Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer
    Abdollahi, Alireza
    Nozarian, Zohreh
    Nazar, Elham
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10
  • [29] Matrix metalloproteinase-2 gene polymorphisms in nasal polyps
    Wang, Ling-Feng
    Chien, Chen-Yu
    Kuo, Wen-Rei
    Tai, Chin-Feng
    Juo, Suh-Hang Hank
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 134 (08) : 852 - 856
  • [30] Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection
    Campbell, LG
    Ramachandran, S
    Liu, W
    Shipley, JM
    Itohara, S
    Rogers, JG
    Moazami, N
    Senior, RM
    Jaramillo, A
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 517 - 528